Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

Summary

This study is a Phase I, dose escalation study of oral darinaparsin for the treatment of advanced solid tumors. Eligible patients could have received any amount of previous therapy.

Timeline

Start

2010-06

Primary completion

2012-04

Completion

2012-04

Drugs

Indications